Integer (NYSE:ITGR) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Integer (NYSE:ITGR) from a hold rating to a buy rating in a research report sent to investors on Saturday.

Several other research firms have also recently issued reports on ITGR. Truist Financial raised their target price on shares of Integer from $86.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, December 18th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Integer in a report on Monday, December 29th. Citigroup upped their price objective on Integer from $69.00 to $75.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Benchmark reiterated a “hold” rating on shares of Integer in a report on Friday, October 24th. Finally, Bank of America downgraded Integer from a “buy” rating to a “neutral” rating and set a $87.00 price target for the company. in a research report on Friday, October 24th. Four analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $98.38.

Integer Trading Up 0.6%

Shares of Integer stock opened at $85.78 on Friday. Integer has a fifty-two week low of $62.00 and a fifty-two week high of $146.36. The business’s fifty day moving average is $74.96 and its two-hundred day moving average is $93.06. The company has a quick ratio of 2.45, a current ratio of 3.71 and a debt-to-equity ratio of 0.70. The firm has a market cap of $3.01 billion, a PE ratio of 35.89, a P/E/G ratio of 0.79 and a beta of 0.78.

Integer (NYSE:ITGR) last released its earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, beating the consensus estimate of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same period last year, the company earned $1.43 earnings per share. Integer’s revenue was up 8.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Analysts anticipate that Integer will post 6.01 earnings per share for the current year.

Integer declared that its Board of Directors has approved a share repurchase program on Tuesday, November 4th that permits the company to repurchase $200.00 million in outstanding shares. This repurchase authorization permits the medical equipment provider to buy up to 8.3% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Insiders Place Their Bets

In related news, VP Tommy P. Thomas sold 884 shares of the stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $70.15, for a total value of $62,012.60. Following the completion of the transaction, the vice president owned 3,596 shares of the company’s stock, valued at approximately $252,259.40. This represents a 19.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Cheryl C. Capps acquired 1,600 shares of the company’s stock in a transaction on Thursday, November 6th. The shares were acquired at an average price of $66.70 per share, for a total transaction of $106,720.00. Following the completion of the acquisition, the director directly owned 11,702 shares in the company, valued at $780,523.40. The trade was a 15.84% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have acquired 5,843 shares of company stock worth $384,771. 2.16% of the stock is owned by insiders.

Institutional Trading of Integer

Several institutional investors have recently added to or reduced their stakes in the stock. Salomon & Ludwin LLC acquired a new position in Integer during the 3rd quarter worth $26,000. Global Retirement Partners LLC lifted its position in shares of Integer by 293.8% during the third quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 238 shares during the last quarter. CWM LLC grew its stake in Integer by 46.1% in the second quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 112 shares in the last quarter. MAI Capital Management increased its holdings in Integer by 220.9% in the second quarter. MAI Capital Management now owns 369 shares of the medical equipment provider’s stock valued at $45,000 after buying an additional 254 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its stake in Integer by 210.5% during the second quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock valued at $66,000 after buying an additional 362 shares in the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer News Roundup

Here are the key news stories impacting Integer this week:

• Negative Sentiment: Multiple firms (Rosen Law Firm) reminded shareholders of a lead‑plaintiff deadline of February 9, 2026 for a securities class action covering purchases between July 25, 2024 and October 22, 2025; investors are being urged to contact counsel. Read More.
• Negative Sentiment: Bleichmar Fonti & Auld (BFA) and related filings notify investors that a class action was filed alleging securities fraud after a significant stock drop; the notice urges affected investors to seek information about potential claims. Read More.
• Negative Sentiment: Kuehn Law states it is investigating whether Integer and certain officers overstated competitive position and long‑term growth from two EP devices, and whether sales deterioration was concealed — specific allegations that amplify potential liability exposure. Read More.
• Negative Sentiment: Levi & Korsinsky, Berger Montague, Bragar Eagel & Squire and other plaintiff firms have issued separate notices seeking clients and reminding investors of the same Feb. 9 deadline — a coordinated wave of filings that increases the probability of consolidated, high‑stakes litigation. Read More.
• Negative Sentiment: Additional national firms (Pomerantz, Glancy Prongay & Murray, The Gross Law Firm, ClaimsFiler, Bronstein, etc.) have published investor alerts and filing reminders — reinforcing market focus on litigation risk and the potential for discovery, damages and settlement costs. Read More.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.